INTRODUCTION
In the United States of America, the 1993 National Institutes of Health (NIH) Consensus Development Conference on Early Identification of Hearing Loss focused unprecedented attention on newborn hearing screening, in general, and especially universal screening. 1 This conference was the catalyst for considerable controversy that still exists years later. A major concern raised by Bess and Paradise 2 was an alleged failure rate of 10% or more for the automated auditory brainstem response (AABR), although no data were offered in support of this claim. This generated the expression of passionate feelings in responses from professionals in a variety of subspecialty areas of medicine as indicated by the many letters to the editor of Pediatrics to refute Bess and Paradise's conclusions that universal screening for infant hearing was not necessarily beneficial and not, at the time, justified. 3 ± 15 Despite the criticism of proposed universal screening, early studies have repeatedly shown that selective screening based on high-risk criteria will detect, at best, only half of all infants with congenital hearing loss. 16, 17 The advent of technological improvements in assessing the hearing of newborn infants in the 1980s and 1990s has made possible the widespread implementation of universal newborn hearing screening in the hospital setting. Despite the recommendation of the NIH, the Joint Committee on Infant Hearing Screening, and the more recent recommendation from the Fetus and Newborn Committee of the American Academy of Pediatrics, 18 many in the field of pediatrics have been reticent to implement this recommendation. This opinion is shared by many despite the fact
OBJECTIVE:
The purpose of the study was to assess the feasibility of performing universal newborn hearing screening in different clinical settings and tracking the infants who did not pass initial screening through their confirmatory testing.
STUDY DESIGN:
Between December 1996 and December 1997, a total of 11,711 infants were enrolled from five clinically different study sites. Universal newborn hearing screening was performed using automated auditory brainstem response ( AABR ) testing. Infants who did not pass the initial screening were tested again prior to discharge. Data regarding the rate of referral for follow -up testing, age of infant at screening, the duration of time required for screening, and type of personnel performing the test were collected. Formal audiology appointments were made prior to discharge for infants who required follow -up testing, and letters were sent with phone calls made to those who failed to keep their appointments for repeat testing. Outpatient testing consisted of a repeat AABR and, if necessary, a diagnostic auditory brainstem -evoked response, otoacoustic emission testing, and tympanometry.
RESULTS:
At the time of hospital discharge, the refer rate was < 2% ( 215 of 11,711 newborns ) using AABR screening. Sensorineural hearing loss ( SNHL ) was confirmed in 32 of these infants, resulting in an overall incidence of confirmed SNHL of 2.7 per thousand newborns. The false -positive rate ranged from 0.3% to 2.5%, with a cumulative false -positive rate of 0.9% ( 1.5% if all infants lost to follow -up are included as false -positives ) . No false -negatives were identified. The average time of testing was 7.1 minutes independent of the personnel performing the testing and the age of testing was < 24 hours in 70% of the infants tested. The total number of infants lost to follow -up was 61 ( 29% of patients referred or 0.5% of the study population ) .
CONCLUSION:
This study demonstrated that the refer rate for universal hearing screening with the AABR was acceptably low when performed by a variety of personnel in typical nursery settings within the first 24 hours after birth. A low rate of screening failures with the AABR minimizes costs associated with subsequent follow -up assessments and lessens any potential impact of false -positive screening on the parent ± newborn relationship. Journal of Perinatology 2000; 20:S127 ± S130.
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that the average age of diagnosis remains at 14 months or greater despite the availability of this new technology. 18 This multisite study was designed to assess the screening failure rate for universal hearing screening using AABR in the typical nursery settings within the first 36 hours of life when performed by a variety of personnel. This study would also assess the feasibility of performing universal newborn hearing screening in hospitals providing various levels of care. Another goal of the study was to assess the adequacy of follow-up for infants initially referred, since one of the major concerns expressed by many experts in the field in the past has been the loss of infants to appropriate follow-up.
METHODS
Five sites were selected to participate in this study based on the principal investigator's interest in universal newborn hearing screening and the presence of an existing universal screening program. A variety of sites were selected to represent private hospitals, as well as university settings. There was also a difference in the level of training of the personnel performing the testing at each of the sites. The sites included Kosair Children's Hospital, Louisville, KY; Baptist Memorial Hospital East, Memphis, TN; Vanderbilt University Medical Center, Nashville, TN; Boulder Community Hospital, Boulder, CO; and Huntsville Hospital, Huntsville, AL.
The duration of the study was from December 1996 to December 1997 and included sites where only well babies or only Newborn Intensive Care Unit (NICU) graduates were tested, as well as sites with a mixture of infants from well-baby nurseries, intermediate care nurseries, and NICU nurseries. During the study period, 11,711 infants were tested during the sleeping state Ð usually postprandial. Testing at all sites was performed using the Algo 2 instrumentation (Natus Medical Incorporated, San Carlos, CA). The stimulus parameters were: type Ð click; duration Ð 0.1 msec; repetitions Ð 500 to 15,000; intensity Ð 35 dB nHL (normal hearing level); rate Ð 34.7 and 37.7 per second; mode of presentation Ð binaurally (different rate/ear). The acquisition parameters included: electrodes Ð high forehead (non-inverting), nape of neck (inverting or reference); filters Ð 100 to 1500 Hz (Hertz); averaging Ð automatic rejection of myogenic or electrical artifact.
If the infant was referred on the first testing, a repeat test was performed prior to hospital discharge using the standard 35 dB click stimulus. Two sites did additional screening with 70/40 dB nHL click stimulus if the infants were not successful on repeat testing using the usual 35-dB click stimulus. This screening started at 40 dB nHL and, if necessary, the test was then performed at 70 dB nHL. The average test time required for testing was tabulated, as well as the refer rate (the percent of newborns who did not pass hospital screening). The personnel varied at each of the sites. The Hunstville site used only audiologists, while Vanderbilt used either audiologists or audiology students. Of the other study sites, most used trained technicians or nursing personnel.
The parents of all infants were given cards with normal speech and language development guidelines to watch their infant's future language development. Parents were given the results of the hearing screen prior to discharge in written and verbal format, and those referred for follow-up testing were given an appointment to see an audiologist within 1 to 2 months following hospital discharge. Letters were sent and phone calls placed two to three times in order to reschedule appointments of those infants who did not keep their scheduled appointment. In addition, two of the study sites also sent notification to the pediatrician's office if the infant did not return for follow-up. Outpatient re-testing consisted of a repeat Algo 2 screen and, if necessary, a diagnostic ABR, otoacoustic emission testing, and tympanometry.
RESULTS
Overall, of 11,711 infants screened between December 1996 and December 1997, 215 ( <2%) were referred following the initial testing in the nursery. True sensorineural hearing loss (SNHL) was confirmed in 32 (2.7/1000) and conductive hearing loss was reported in eight infants (0.7/1000). The positive predictive value of an abnormal screening test was 28%. A total of 61 infants were lost to follow-up (29% of the patients referred or 0.5% of the study population). Time required for hospital screening averaged 7.1 minutes (median Ð 5.2 minutes; range Ð 30 seconds to 22.1 minutes), which included only the time that the AABR was running but did not include preparation or documentation time. Greater than 70% of the infants were tested in the first 24 hours of life. The two sites which did additional screening with 70/40 dB nHL prior to discharge lowered the discharge refer rate from 7% to 3% in one center and from 2% to 1% in the other study site.
At Kosair Children's Hospital, the study population consisted primarily of well-baby subjects, with nurses and/or technicians performing the testing. Referrals were made to audiologists at a university hospital center who were not directly participating in this study. Average time of testing was 28 hours following birth, with the average discharge time of 48 hours. There were 6061 infants tested with a refer rate at discharge of 1% (66 infants). Of these 66 infants, 14 infants had confirmed SNHL (three unilateral; 11 bilateral); 30 (45%) were lost to follow-up; one infant died; 21 passed outpatient screens, giving a false-positive rate of 0.3%.
At Baptist Memorial Hospital in Memphis, newborns from the well-baby nursery were tested in the first 24 hours of life by nonvolunteer technicians. Referrals were made to in-house audiologists. A total of 1563 infants were tested with 53 (3%) referring. Of these 53 infants, seven were lost to follow-up and six had confirmed hearing loss (four with SNHL [two bilateral; two unilateral] and two with conductive hearing loss). The remaining 40 infants passed outpatient screening, resulting in a false-positive rate of 2.5%.
At Boulder Community Hospital, universal screening was performed primarily in the well-baby nursery, although all infants in the level 2 nursery were also offered screening. Trained volunteers performed the testing. Average age of testing was 21 hours, with age at discharge averaging 24 hours. A total of 1228 infants were tested with 37 (3%) referrals. Of these 37 patients, only four infants were lost to follow-up, with 27 passing the outpatient screen for a falsepositive rate of 2%. There were five infants with confirmed SNHL (two bilateral; three unilateral) and the results for one infant were not recorded as to the type of hearing loss.
Also included in the study was the well-baby nursery at Huntsville Hospital in Alabama. At this location, the average age at testing was 28 hours and the average length of stay was 48 hours. A total of 2071 infants were screened with 12 (1%) referrals being sent to the inhouse audiologists. Of these 12 infants, five infants were lost to follow-up (42%) and five infants passed outpatient re-screens for a false-positive of 2.5%. Two infants had confirmed SNHL (one bilateral; one unilateral). One of these infants was suspected of having an auditory neuropathy since the patient referred on the AABR screening, but subsequently passed the otoacoustic emission testing.
The highest-risk population, NICU graduates, were tested at Vanderbilt University. Audiologists, audiology students, and a small number of technicians performed the testing. A total of 788 infants were tested with 47 (6%) referred for retesting. Of these 47 infants, 15 (32%) were lost to follow-up and 12 infants had confirmed hearing loss (seven with SNHL [two unilateral; five bilateral] and five conductive hearing loss). Two infants expired, and 18 of the patients referred on initial testing passed outpatient screening for a false-positive rate of 2%.
Of the infants who failed the newborn hearing screen prior to discharge in one ear (unilateral refers), 90 of 137 returned for outpatient screening. Most of the re-screens for unilateral refers were performed with the Algo 2. Other methods of performing re-screens included: diagnostic ABRs (eight patients); otoacoustic emissions (11 patients), and behavioral audiometry (one patient). Seventeen of 90 patients who returned for re-testing had conductive or SNHL. Forty-seven (34%) of the unilateral refer patients did not return for follow-up testing. Table 1 includes a summary of data from all study sites.
Of 73 patients who were retested following a unilateral screening failure, all but one passed the outpatient testing in the ear that originally passed. The single exception was an infant who was subsequently diagnosed with a mild conductive hearing loss in the ear which had passed the original screening test. This did not represent a false-negative, but an acquired conductive hearing loss secondary to serous fluid in the middle ear.
DISCUSSION
Newborn hearing screening has been advocated and performed in the United States since the pioneer work of Downs and Sterritt 19 in 1964. The incidence of congenital hearing loss is shown from the Colorado experience to be alarmingly high, with bilateral hearing loss present in at least 1 of 500 newborns. For comparison, the incidence of commonly screened newborn disorders includes: galactosemia Ð 2/100,000; phenylketonuria Ð 10/100,000; hypothyroidism Ð 25/100,000; and bilateral SNHL Ð 200/100,000. 20 In the past, time requirements and the subjectiveness of behavioral measurements for assessing hearing impairment made widespread testing impractical. Despite great observational skills, parents are eternal optimists and often do not choose to believe during the first years of life that their child might have a hearing loss. Often, even the physician caring for the child is remiss in failing to aggressively pursue the diagnosis when informed by the parents that they suspect something is not right with the child's speech and Unilateral congenital hearing loss is a relatively minor disability in the overall picture of language and cognitive development, but it is nevertheless an educational disability that can be minimized by early management and intervention. Bess and Tharpe 22 showed in 1986 that 50% of children with unilateral hearing loss will be retained in one educational grade in school or will need resource assistance in school. In our study, we found that 17 of 90 (19%) infants who had initially failed screening in only one ear and returned for repeat testing were subsequently confirmed with a unilateral hearing loss.
The American Academy of Pediatrics 18 statement on detection and intervention for newborn and infant hearing loss recommends that refer rates be <4%. This criterion was met in four of the five sites. Vanderbilt had an 8.5% refer rate, but tested only NICU patients considered at higher risk for SNHL. All of the study sites achieved a false-positive rate of <3% and had no false-negatives. This meets the guidelines for the screening element of a universal newborn hearing screening program.
We found that the AABR is an acceptable method for universal newborn hearing screening. Test performance is independent of screening personnel and timing of screening after birth. Test time is reasonably short (7 minutes) for most infants. We report an average final refer rate of <2%, with false-positive rate ranging from 0.3% to 2.5%. This supports our hypothesis that universal newborn hearing screening is feasible in a variety of hospital settings and using different testing personnel.
One significant problem continues to be those infants lost to follow-up despite the best efforts of the staff who administer the testing, and their emphasis on the importance of compliance with appropriate follow-up recommendations. Overall, of 210 infants who failed initial screening, 61 infants (29%) did not complete the recommended outpatient testing. According to the above guidelines, the proportion of infants lost to follow-up should not exceed 5%. Only one study site was able to achieve this goal. Clearly, the challenge to identify all children with significant hearing loss makes an even stronger argument for low refer rates at discharge because of the difficulty in assuring compliance with appropriate and timely follow-up.
